Balanced news tone
News Sentiment
ABT sentiment intelligence
Abbott Laboratories news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
73/100 classification confidence.
directly relevant articles
high-authority source matches
-1.5% over one week, +6.5% over four weeks, trend inactive, and near fair-value range.
J&J Slipped On Its Report; Why It Bodes Well For Intuitive, Abbott, Others
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Abbott Laboratories stock stays supported by diversified health-care business
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 18:17
- Source
- Ad Hoc News
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Jul 2026 14:49
- Source
- Market source
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 07:00
- Source
- Market source
Abbott Laboratories' Q2 2026 Earnings: What to Expect
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Jun 2026 07:00
- Source
- Market source
How Does Wall Street View Abbott Laboratories (ABT)’s Outlook?
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Market source
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 07:00
- Source
- Market source
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- TradingView
Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- StockStory
Abbott (NYSE: ABT) holders back 2026 stock plan, expand board
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 22 Apr 2026 07:00
- Source
- 24/7 Wall St.
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
Abbott Laboratories (ABT) Margin Drop To 13.9% Challenges Bullish Earnings Narratives
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Apr 2026 07:00
- Source
- simplywall.st
[8-K] ABBOTT LABORATORIES Reports Material Event
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Stock Titan
Abbott Laboratories Insiders Added US$3.10m Of Stock To Their Holdings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- Market source
Abbott Laboratories price faces negative outlook - Forecast today - 10-04-2026
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 10 Apr 2026 07:00
- Source
- Economies.com
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Reasons to Retain Abbott Stock in Your Portfolio Now
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Apr 2026 07:00
- Source
- TradingView
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences Acquisition - News and Statistics
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Mar 2026 07:00
- Source
- IndexBox
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
Dividend Aristocrats In Focus: Abbott Laboratories
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 28 Jan 2026 08:00
- Source
- Sure Dividend
Don't Ignore The Insider Selling In Abbott Laboratories
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Dec 2025 08:00
- Source
- simplywall.st
Abbott Laboratories' (NYSE:ABT) Earnings Are Weaker Than They Seem
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Nov 2025 08:00
- Source
- simplywall.st